Cargando…

Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009–2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients

Background. The impact of neuraminidase inhibitor (NAI) treatment on clinical outcomes of public health importance during the 2009–2010 pandemic has not been firmly established. Methods. We conducted a systematic review and meta-analysis, searching 11 databases (2009 through April 2012) for relevant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muthuri, Stella G., Myles, Puja R., Venkatesan, Sudhir, Leonardi-Bee, Jo, Nguyen-Van-Tam, Jonathan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549600/ https://www.ncbi.nlm.nih.gov/pubmed/23204175 http://dx.doi.org/10.1093/infdis/jis726

Ejemplares similares

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis
por: Venkatesan, Sudhir, et al.
Publicado: (2017)

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010–2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel
por: Laguio-Vila, Maryrose R., et al.
Publicado: (2014)

Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage
por: Watson, Samuel I., et al.
Publicado: (2017)

Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations
por: Laidler, Matthew R., et al.
Publicado: (2015)

Chikungunya Outbreak in Kedougou, Southeastern Senegal in 2009–2010
por: Sow, Abdourahmane, et al.
Publicado: (2017)

Nosocomial Pandemic (H1N1) 2009, United Kingdom, 2009–2010
por: Enstone, Joanne E., et al.
Publicado: (2011)

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014)

Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination
por: Ohfuji, Satoko, et al.
Publicado: (2011)

Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors
por: Delgado-Rodríguez, Miguel, et al.
Publicado: (2012)

Supply of Neuraminidase Inhibitors Related to Reduced Influenza A (H1N1) Mortality during the 2009–2010 H1N1 Pandemic: An Ecological Study
por: Miller, Paula E., et al.
Publicado: (2012)

CD4(+) T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine
por: Nayak, Jennifer L., et al.
Publicado: (2013)

Dysregulated T-Helper Type 1 (Th1):Th2 Cytokine Profile and Poor Immune Response in Pregnant Ferrets Infected With 2009 Pandemic Influenza A(H1N1) Virus
por: Yoon, Sun-Woo, et al.
Publicado: (2018)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors
por: Tolah, Ahmed M., et al.
Publicado: (2016)

The long road of pandemic vaccine development to rollout: A systematic review on the lessons learnt from the 2009 H1N1 influenza pandemic
por: Ankomah, Alex Asamoah, et al.
Publicado: (2022)

Molecular evolution of the hemagglutinin and neuraminidase genes of pandemic (H1N1) 2009 influenza viruses in Sendai, Japan, during 2009–2011
por: Khandaker, Irona, et al.
Publicado: (2013)

Viruses Associated With Acute Respiratory Infections and Influenza-like Illness Among Outpatients From the Influenza Incidence Surveillance Project, 2010–2011
por: Fowlkes, Ashley, et al.
Publicado: (2014)

The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
por: Klein, Eili Y, et al.
Publicado: (2020)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Transmission of pandemic influenza H1N1 (2009) in Vietnamese swine in 2009–2010
por: Trevennec, Karen, et al.
Publicado: (2011)

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
por: Myles, Puja R, et al.
Publicado: (2012)

Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010–2015
por: Tewawong, Nipaporn, et al.
Publicado: (2018)

Genome Stability of Pandemic Influenza A (H1N1) 2009 Based on Analysis of Hemagglutinin and Neuraminidase Genes
por: Espínola, Emilio E
Publicado: (2012)

Comparative thermostability analysis of zoonotic and human influenza virus A and B neuraminidase
por: Evseenko, Vasily A., et al.
Publicado: (2019)

Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic
por: Lo, Chia-Yun, et al.
Publicado: (2017)

A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
por: Marcelin, Glendie, et al.
Publicado: (2011)

Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus
por: Quiliano, MiguelMiguel, et al.
Publicado: (2013)

Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009–2017
por: Adlhoch, Cornelia, et al.
Publicado: (2019)

Rapid Detection of Reassortment of Pandemic H1N1/2009 Influenza Virus
por: Poon, Leo L M, et al.
Publicado: (2010)

Influenza A/H1N1 2009 Pandemic and Respiratory Virus Infections, Beijing, 2009–2010
por: Yang, Yaowu, et al.
Publicado: (2012)

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010–2011 to 2015–2016, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Heterologous Prime-Boost Vaccination Using an AS03(B)-Adjuvanted Influenza A(H5N1) Vaccine in Infants and Children <3 Years of Age
por: Nolan, Terry, et al.
Publicado: (2014)

Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites
por: Maurer-Stroh, Sebastian, et al.
Publicado: (2009)

Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection
por: Ingram, Paul Robert, et al.
Publicado: (2010)

The Clinical Usefulness of the SD Bioline Influenza Antigen Test® for Detecting the 2009 Influenza A (H1N1) Virus
por: Choi, Won Suk, et al.
Publicado: (2011)

Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis
por: Caspard, Herve, et al.
Publicado: (2017)

Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009–2010
por: McLeish, Nigel J., et al.
Publicado: (2011)

Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient
por: Kodiyanplakkal, Rosy Priya L, et al.
Publicado: (2019)

Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
por: Petrie, Joshua G., et al.
Publicado: (2016)

Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England
por: Andrews, Nick, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5fkjuvfvp09g7c2g09rhkctor0